Clorox (NYSE:CLX) Full Year 2025 Results
Key Financial Results
- Revenue: US$7.10b (flat on FY 2024).
- Net income: US$810.0m (up 189% from FY 2024).
- Profit margin: 11% (up from 3.9% in FY 2024).
- EPS: US$6.56 (up from US$2.26 in FY 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Clorox EPS Beats Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 12%.
The primary driver behind last 12 months revenue was the Health and Wellness segment contributing a total revenue of US$2.70b (38% of total revenue). Notably, cost of sales worth US$3.90b amounted to 55% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$1.13b (47% of total expenses). Explore how CLX's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Household Products industry in the US.
Performance of the American Household Products industry.
The company's shares are down 1.7% from a week ago.
Risk Analysis
You should always think about risks. Case in point, we've spotted 1 warning sign for Clorox you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.